Cargando…

BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model

Detalles Bibliográficos
Autor principal: Dirican, Ebubekir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294037/
https://www.ncbi.nlm.nih.gov/pubmed/31983154
http://dx.doi.org/10.31557/APJCP.2020.21.1.1
_version_ 1783546401632813056
author Dirican, Ebubekir
author_facet Dirican, Ebubekir
author_sort Dirican, Ebubekir
collection PubMed
description
format Online
Article
Text
id pubmed-7294037
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-72940372020-06-29 BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model Dirican, Ebubekir Asian Pac J Cancer Prev Letter to Editor West Asia Organization for Cancer Prevention 2020 /pmc/articles/PMC7294037/ /pubmed/31983154 http://dx.doi.org/10.31557/APJCP.2020.21.1.1 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Dirican, Ebubekir
BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
title BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
title_full BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
title_fullStr BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
title_full_unstemmed BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
title_short BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
title_sort braf, kras and pik3ca mutation and sensitivity to trastuzumab in breast cancer cell line model
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294037/
https://www.ncbi.nlm.nih.gov/pubmed/31983154
http://dx.doi.org/10.31557/APJCP.2020.21.1.1
work_keys_str_mv AT diricanebubekir brafkrasandpik3camutationandsensitivitytotrastuzumabinbreastcancercelllinemodel